ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Medella Therapeutics Limited

Medella Therapeutics Limited is a dissolved company incorporated on 8 February 2007 with the registered office located in Sheffield, South Yorkshire. Medella Therapeutics Limited was registered 18 years ago.
Status
Dissolved
Dissolved on 26 February 2019 (6 years ago)
Was 12 years old at the time of dissolution
Via compulsory strike-off
Company No
06090354
Private limited company
Age
18 years
Incorporated 8 February 2007
Size
Micro
Turnover is under £1M
Balance sheet is under £500,000
Under 10 employees
Confirmation
Not Submitted
Awaiting first confirmation statement
Accounts
Not Submitted
Awaiting first accounts
Address
The Innovation Centre
217 Portobello
Sheffield
S1 4DP
England
Same address for the past 7 years
Telephone
Unreported
Email
Unreported
People
Officers
3
Shareholders
3
Controllers (PSC)
1
Director • British • Lives in England • Born in Apr 1982
Director • Scientist • British • Lives in UK • Born in Apr 1956
Fusion Ip Sheffield Limited
PSC
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Top Technology Ventures Limited
Ip2ipo Services Limited is a mutual person.
Active
Ip2ipo Innovations Limited
Ip2ipo Services Limited is a mutual person.
Active
Ieso Digital Health Limited
Ip2ipo Services Limited is a mutual person.
Active
Ip2ipo Limited
Ip2ipo Services Limited is a mutual person.
Active
Asterion Limited
Ip2ipo Services Limited is a mutual person.
Active
Fusion Ip Sheffield Limited
Ip2ipo Services Limited is a mutual person.
Active
Technology Transfer Consultancy Limited
Dr Timothy Skerry is a mutual person.
Active
Ip2ipo Nominees Limited
Ip2ipo Services Limited is a mutual person.
Active
Financials
Net Assets, Total Assets & Total Liabilities (2008–2016)
Period Ended
31 Dec 2016
For period 31 Dec31 Dec 2016
Traded for 12 months
Cash in Bank
£5.5K
Decreased by £5.21K (-49%)
Turnover
Unreported
Same as previous period
Employees
Unreported
Same as previous period
Total Assets
£13.43K
Decreased by £4.99K (-27%)
Total Liabilities
-£981.06K
Increased by £20.31K (+2%)
Net Assets
-£967.63K
Decreased by £25.3K (+3%)
Debt Ratio (%)
7303%
Increased by 2088.98% (+40%)
Latest Activity
Compulsory Dissolution
6 Years Ago on 26 Feb 2019
Compulsory Gazette Notice
6 Years Ago on 11 Dec 2018
Registered Address Changed
7 Years Ago on 27 Jul 2018
Confirmation Submitted
7 Years Ago on 21 Feb 2018
Full Accounts Submitted
8 Years Ago on 6 Oct 2017
Confirmation Submitted
8 Years Ago on 15 Feb 2017
Full Accounts Submitted
9 Years Ago on 10 Oct 2016
Ip2Ip0 Services Limited Resigned
9 Years Ago on 22 Jul 2016
Confirmation Submitted
9 Years Ago on 17 Feb 2016
Small Accounts Submitted
10 Years Ago on 23 Sep 2015
Get Credit Report
Discover Medella Therapeutics Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Final Gazette dissolved via compulsory strike-off
Submitted on 26 Feb 2019
First Gazette notice for compulsory strike-off
Submitted on 11 Dec 2018
Registered office address changed from The Sheffield Bioincubator 40 Leavygreave Road Sheffield South Yorkshire S3 7rd to The Innovation Centre 217 Portobello Sheffield S1 4DP on 27 July 2018
Submitted on 27 Jul 2018
Confirmation statement made on 8 February 2018 with no updates
Submitted on 21 Feb 2018
Full accounts made up to 31 December 2016
Submitted on 6 Oct 2017
Confirmation statement made on 8 February 2017 with updates
Submitted on 15 Feb 2017
Full accounts made up to 31 December 2015
Submitted on 10 Oct 2016
Termination of appointment of Ip2Ip0 Services Limited as a director on 22 July 2016
Submitted on 12 Aug 2016
Annual return made up to 8 February 2016 with full list of shareholders
Submitted on 17 Feb 2016
Total exemption small company accounts made up to 31 December 2014
Submitted on 23 Sep 2015
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year